Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | EPAS1 | Q99814 | 4/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 4/20 | 0.35 |
| ▸ | CA12 | O43570 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | ARNT | P27540 | 1/20 | 0.33 |
| ▸ | VEGFA | P15692 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9957670 | 0.87 | ALDH1A1 (0.44) | ALDH1A1PTGS1PTGS2CA2GAA | |
| SCHEMBL17355707 | 0.87 | HPGD (0.36) | ALDH1A1EPAS1HPGDCA2CA12 | |
| SCHEMBL12871602 | 0.82 | FABP3 (0.34) | ALDH1A1EPAS1HPGD | |
| SCHEMBL17356310 | 0.82 | SCN9A (0.37) | ALDH1A1EPAS1PTGS1PTGS2CA2 | |
| SCHEMBL927493 | 0.82 | ALDH1A1 (0.45) | ALDH1A1HPGDCA2CA12KDM4E | |
| SCHEMBL780326 | 0.80 | CES2 (0.35) | EPAS1PTGS1PTGS2CA12IDO1 | |
| SCHEMBL3738486 | 0.79 | HPGD (0.39) | ALDH1A1HPGDCA2CA12KDM4E | |
| SCHEMBL3742274 | 0.79 | CA1 (0.45) | ALDH1A1PTGS1PTGS2HPGDCA2 | |
| SCHEMBL3848319 | 0.78 | CES2 (0.33) | EPAS1PTGS1PTGS2CA12VEGFA | |
| SCHEMBL26664900 | 0.78 | ELANE (0.34) | EPAS1PTGS1PTGS2CA12IDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8512897-B2 | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES, LTD. (JP) | 2013-08-20 | — | — | US | claimed |
| EP-3306732-B1 | NONAQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS INC (JP) | 2025-06-25 | — | — | EP | disclosed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-115043844-B | TRK kinase inhibitor compounds and uses thereof | 河南迈英诺医药科技有限公司 | 2024-05-17 | — | — | CN | disclosed |
| CN-115043844-A | TRK kinase inhibitor compounds and uses thereof | 河南迈英诺医药科技有限公司 | 2022-09-13 | — | — | CN | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| CN-107534185-B | Nonaqueous electrolyte for battery and lithium secondary battery | 三井化学株式会社 | 2021-10-08 | — | — | CN | disclosed |
| EP-3343687-B1 | NON-AQUEOUS ELECTROLYTE SOLUTION FOR BATTERIES AND LITHIUM SECONDARY BATTERY COMPRISING THE SAME | MITSUI CHEMICALS INC (JP) | 2021-02-24 | — | — | EP | disclosed |
| EP-3621141-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2020-03-11 | — | — | EP | disclosed |
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | MITSUI CHEMICALS, INC. (JP) | 2017-11-30 | — | — | US | disclosed |
| EP-3211706-A1 | LITHIUM SECONDARY BATTERY | Mitsui Chemicals, Inc. (JP) | 2017-08-30 | — | — | EP | disclosed |
| CN-107078338-A | Lithium secondary battery | 三井化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-20170084955-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2017-03-23 | — | — | US | disclosed |
| US-20150056503-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2015-02-26 | — | — | US | disclosed |
| US-8512897-B2 | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES, LTD. (JP) | 2013-08-20 | — | — | US | disclosed |
| CN-101842349-B | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES | 2013-07-17 | — | — | CN | disclosed |
| US-20100291437-A1 | PHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION USING THE SAME, AND LITHIUM BATTERY | UBE INDUSTRIES, LTD. (JP) | 2010-11-18 | — | — | US | disclosed |
| CN-101842349-A | Phenyl sulfonate compound, nonaqueous electrolyte solution using the same, and lithium battery | UBE INDUSTRIES | 2010-09-22 | — | — | CN | disclosed |
| EP-2012386-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Mitsubishi Chemical Corporation (JP) | 2009-01-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291437-A1 | PHENYL SULFONATE COMPOUND, NONAQUEOUS ELECTROLYTE SOLUTION USING THE SAME, AND LITHIUM BATTERY | SLC9B2, SLC13A5, KCNN2 | ALDH1A1 2590/4885EPAS1 2845/4885PTGS1 4152/4885 |
| US-20170346127-A1 | LITHIUM SECONDARY BATTERY | SLC9B2, SCN11A, NUCB2 | ALDH1A1 3428/4885EPAS1 4676/4885PTGS1 4229/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.